Ann Intern Med

1. EMANUEL EJ, Skorton DJ
   Mandating COVID-19 Vaccination for Health Care Workers.
   Ann Intern Med. 2021 Jul 30. doi: 10.7326/M21-3150.
   

   >> Share

   
   

   
   Arch Virol

2. LIU J, Zhang P, Chen Y, Zhong W, et al
   Vaccination with virus-like particles of atypical porcine pestivirus inhibits virus replication in tissues of BALB/c mice.
   Arch Virol. 2021 Jul 28. pii: 10.1007/s00705-021-05185.
   

   >> Share

   
   

   
   BMJ

3. WISE J
   Covid-19: NICE issues guidance on vaccine induced immune thrombocytopenia and thrombosis.
   BMJ. 2021;374:n1914.
   

   >> Share

   
   
4. MAHASE E
   Covid-19: Countries dump vaccines as demand slumps and sharing proves difficult.
   BMJ. 2021;374:n1893.
   

   >> Share

   
   
5. TANNE JH
   Covid-19: US public health officials urge FDA to decide on booster vaccines.
   BMJ. 2021;374:n1877.
   

   >> Share

   
   
6. SAXENA S, Skirrow H, Wighton K
   Should the UK vaccinate children and adolescents against covid-19?
   BMJ. 2021;374:n1866.
   

   >> Share

   
   

   
   Clin Infect Dis

7. CHEN X, Chen Z, Azman AS, Sun R, et al
   Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
   Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
   

   >> Share

   
   
8. NAUCLER P, Galanis I, Petropoulos A, Granath F, et al
   Chronic disease and immunosuppression increase the risk for non-vaccine serotype pneumococcal disease - a nationwide population-based study.
   Clin Infect Dis. 2021 Jul 24. pii: 6327794. doi: 10.1093.
   

   >> Share

   
   
9. CHEN LL, Lu L, Choi CY, Cai JP, et al
   Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
   Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
   

   >> Share

   
   
10. BOLLAERTS K, Fletcher MA, Suaya JA, Hanquet G, et al
    Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.
    Clin Infect Dis. 2021 Jul 27. pii: 6329127. doi: 10.1093.
    

    >> Share

    
    
11. GHAMANDE S, Shaver C, Murthy K, Raiyani C, et al
    Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Clin Infect Dis. 2021 Jul 28. pii: 6329674. doi: 10.1093.
    

    >> Share

    
    

    
    Indian Pediatr

12. KASI SG, Dhir SK, Shivananda S, Marathe S, et al
    Breastfeeding and Coronavirus Disease 2019 (COVID-19) Vaccination: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices.
    Indian Pediatr. 2021;58:647-649.
    

    >> Share

    
    

    
    Infect Immun

13. DANIEL S, Pichugin A, Torano H, Renn JP, et al
    Plasmodium pre-erythrocytic vaccine antigens enhance sterile protection in mice induced by circumsporozoite protein.
    Infect Immun. 2021 Jul 26:IAI0016521. doi: 10.1128/IAI.00165.
    

    >> Share

    
    
14. HIGGINSON EE, Panda A, Toapanta FR, Terzi MC, et al
    Immunogenicity and efficacy of live-attenuated Salmonella Typhimurium vaccine candidate CVD 1926 in a rhesus macaque model of gastroenteritis.
    Infect Immun. 2021 Jul 26:IAI0008721. doi: 10.1128/IAI.00087.
    

    >> Share

    
    

    
    J Immunol

15. SPENCER DA, Malherbe DC, Vazquez Bernat N, Adori M, et al
    Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.
    J Immunol. 2021 Jan 20. pii: jimmunol.2001082. doi: 10.4049/jimmunol.2001082.
    

    >> Share

    
    
16. CHANDRA J, Teoh SM, Kuo P, Tolley L, et al
    Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy.
    J Immunol. 2021;206:987-998.
    

    >> Share

    
    
17. SANDBERG JT, Ols S, Lofling M, Varnaite R, et al
    Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    J Immunol. 2021 Jul 28. pii: jimmunol.2001381. doi: 10.4049/jimmunol.2001381.
    

    >> Share

    
    

    
    J Infect

18. MOMBELLI M, Hoschler K, Cavassini M, Pascual M, et al
    Seasonal Trivalent Inactivated Influenza Vaccine with Topical Imiquimod in Immunocompromised Patients: a Randomized Controlled Trial.
    J Infect. 2021 Jul 20. pii: S0163-4453(21)00353.
    

    >> Share

    
    
19. LADHANI SN
    Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
    

    >> Share

    
    
20. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    

    >> Share

    
    
21. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    

    >> Share

    
    

    
    J Infect Dis

22. EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
    Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
    J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
    

    >> Share

    
    
23. WINER RL, Lin J, Querec TD, Unger ER, et al
    Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women.
    J Infect Dis. 2021 Jul 28. pii: 6329629. doi: 10.1093.
    

    >> Share

    
    

    
    JAMA

24. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    

    >> Share

    
    
25. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    

    >> Share

    
    
26. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    

    >> Share

    
    
27. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    

    >> Share

    
    

    
    Lancet

28. ADEPOJU P
    Ebola returns to Guinea and DR Congo.
    Lancet. 2021;397:781.
    

    >> Share

    
    
29. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    

    >> Share

    
    
30. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    

    >> Share

    
    
31. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    

    >> Share

    
    
32. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

33. LEE JT, Althomsons SP, Wu H, Budnitz DS, et al
    Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network - United States, March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1036-1039.
    

    >> Share

    
    
34. RUBIN D, Eisen M, Collins S, Pennington JW, et al
    SARS-CoV-2 Infection in Public School District Employees Following a District-Wide Vaccination Program - Philadelphia County, Pennsylvania, March 21-April 23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1040-1043.
    

    >> Share

    
    
35. CHRISTIE A, Brooks JT, Hicks LA, Sauber-Schatz EK, et al
    Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1044-1047.
    

    >> Share

    
    
36. KHETSURIANI N, Mosina L, Van Damme P, Mozalevskis A, et al
    Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1029-1035.
    

    >> Share

    
    

    
    N Engl J Med

37. BERGWERK M, Gonen T, Lustig Y, Amit S, et al
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
    

    >> Share

    
    
38. RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
    N Engl J Med. 2021;385:e21.
    

    >> Share

    
    

    
    Nat Med

39. LUCAS C, Klein J, Sundaram ME, Liu F, et al
    Delayed production of neutralizing antibodies correlates with fatal COVID-19.
    Nat Med. 2021;27:1178-1186.
    

    >> Share

    
    
40. KHOURY DS, Cromer D, Reynaldi A, Schlub TE, et al
    Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
    Nat Med. 2021;27:1205-1211.
    

    >> Share

    
    
41. SINGH J, Rahman SA, Ehtesham NZ, Hira S, et al
    SARS-CoV-2 variants of concern are emerging in India.
    Nat Med. 2021;27:1131-1133.
    

    >> Share

    
    
42. ALOBO M
    Strengthened health systems are needed to tackle COVID-19 in Africa.
    Nat Med. 2021;27:1126-1127.
    

    >> Share

    
    
43. BARBERIA LG, Costa SF, Sabino EC
    Brazil needs a coordinated and cooperative approach to tackle COVID-19.
    Nat Med. 2021;27:1133-1134.
    

    >> Share

    
    
44. SCHMIDT T, Klemis V, Schub D, Mihm J, et al
    Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
    Nat Med. 2021 Jul 26. pii: 10.1038/s41591-021-01464.
    

    >> Share

    
    
45. DEMING ME, Lyke KE
    A 'mix and match' approach to SARS-CoV-2 vaccination.
    Nat Med. 2021 Jul 26. pii: 10.1038/s41591-021-01463.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

46. NYAKU M, Richardson E, Martinon-Torres F, Kuter BJ, et al
    Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine): Clinical Trials of Healthy Children and Adults Published Between 2010 and 2019.
    Pediatr Infect Dis J. 2021 Jul 22. pii: 00006454-900000000-95729.
    

    >> Share

    
    

    
    Pediatrics

47. LERNER C, Albertin C, Casillas A, Duru OK, et al
    Patient Portal Reminders for Pediatric Influenza Vaccinations: A Randomized Clinical Trial.
    Pediatrics. 2021 Jul 28. pii: peds.2020-048413. doi: 10.1542/peds.2020-048413.
    

    >> Share

    
    
48. WYNN CS, Stephens AB, Stockwell MS
    The Potential Role of Patient Portals to Improve Influenza Vaccination.
    Pediatrics. 2021 Jul 28. pii: peds.2021-049932. doi: 10.1542/peds.2021-049932.
    

    >> Share

    
    

    
    PLoS One

49. KUHN R, Henwood B, Lawton A, Kleva M, et al
    COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA.
    PLoS One. 2021;16:e0255246.
    

    >> Share

    
    
50. DEPELSENAIRE ACI, Witham K, Veitch M, Wells JW, et al
    Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
    PLoS One. 2021;16:e0255282.
    

    >> Share

    
    
51. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    

    >> Share

    
    
52. CLAVE LLAVALL A, de Wildt G, Meza G, Tattsbridge J, et al
    Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV) vaccination program in Iquitos, Peru: A qualitative study.
    PLoS One. 2021;16:e0255218.
    

    >> Share

    
    
53. JOSHUA PE, Nwauzor CO, Odimegwu DC, Ukachukwu UG, et al
    Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice.
    PLoS One. 2021;16:e0246915.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

54. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
55. 
    Correction for Madan et al., Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
56. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
57. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    

    
    Science

58. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    

    >> Share

    
    

    
    Vaccine

59. CORCORAN M, Mereckiene J, Cotter S, Murchan S, et al
    Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00741.
    

    >> Share

    
    
60. INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
    M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
    

    >> Share

    
    
61. HECHT J, Suliman S, Wegiel B
    Bacillus Calmette-Guerin (BCG) vaccination to treat endometriosis.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00879.
    

    >> Share

    
    
62. CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
    

    >> Share

    
    
63. INSERRA F, Tajer C, Antonietti L, Mariani J, et al
    Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.
    

    >> Share

    
    
64. JACKSON B, Harvey Y, Perez-Martin E, Wilsden G, et al
    The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
    Vaccine. 2021 Jul 21. pii: S0264-410X(21)00860.
    

    >> Share

    
    
65. BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
    Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
    

    >> Share

    
    
66. VINK M, Upadhaya N, Amin HA, Liwal MG, et al
    Does support to Private Health Practitioners increase childhood vaccination coverage? Findings from a comparative study in Afghanistan.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00877.
    

    >> Share

    
    
67. HAYMAN B, Suri R, Prasad SD
    COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
    

    >> Share

    
    
68. KHAN SA, Choudhury P, Kakati S, Doley R, et al
    Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00919.
    

    >> Share

    
    
69. KUROKAWA N, Lavoie PO, D'Aoust MA, Couture MM, et al
    Development and characterization of a plant-derived rotavirus-like particle vaccine.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00916.
    

    >> Share

    
    
70. KLEIN NP, Peyrani P, Yacisin K, Caldwell N, et al
    A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00863.
    

    >> Share

    
    
71. PAUL E, Brown GW, Kalk A, Ridde V, et al
    Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.
    

    >> Share

    
    
72. LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
    The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.
    

    >> Share

    
    
73. ALVES MLF, Ferreira MRA, Donassolo RA, Rodrigues RR, et al
    Clostridium septicum: A review in the light of alpha-toxin and development of vaccines.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00878.
    

    >> Share

    
    
74. MADHIVANAN P, Krupp K, Coudray M, Colbert B, et al
    Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.
    Vaccine. 2021 Jul 19. pii: S0264-410X(21)00903.
    

    >> Share

    
    
75. FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
    An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
    

    >> Share

    
    
76. VODICKA E, Nonvignon J, Antwi-Agyei KO, Bawa J, et al
    The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana.
    Vaccine. 2021 Jul 21. pii: S0264-410X(21)00904.
    

    >> Share

    
    
77. COLTON H, Greenfield DM, Snowden JA, Miller PDE, et al
    Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant.
    Vaccine. 2021 Jul 19. pii: S0264-410X(21)00881.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share